介入器械伪影减少:光子计数探测器CT虚拟单能图像与迭代金属伪影减少算法的应用
本研究在腹部体模上评估光子计数探测器CT(PCDCT)介入扫描中,迭代金属伪影减少算法(iMAR)联合虚拟单能图像(VMI)对伪影的减少效果。共评估96个扫描序列,结果显示iMAR神经线圈联合150 keV与190 keV VMI伪影减少最显著(中位评级1,标准为4),定性分析偏好iMAR神经线圈联合70 keV VMI,定量分析显示iMAR神经线圈联合190 keV VMI伪影表达最低(平均20.06 HU,标准为167.98 HU,P<0.0001)。
要点
- iMAR神经线圈联合150 keV或190 keV VMI在PCDCT介入扫描中伪影减少最显著(中位评级1,标准为4)。
- 定性分析偏好iMAR神经线圈联合70 keV VMI;190 keV VMI图像质量下降(中位评级3,70 keV为5)。
- 定量分析显示iMAR神经线圈联合190 keV VMI伪影表达最低(平均20.06 HU,标准为167.98 HU,P<0.0001)。
核心结论
- VMI与iMAR技术协同应用可显著减少PCDCT介入扫描中介入器械相关伪影;iMAR神经线圈联合70 keV VMI是首选组合,可提高周围组织和靶病变的诊断可评估性。
研究设计与样本
- 使用腹部体模在PCDCT上进行评估,采用4种穿刺器械、2种扫描模式(QuantumSn 100 kV、Quantumplus 140 kV),共评估96个不同扫描序列;重建包括无iMAR、iMAR(7种金属预设)及iMAR联合VMI(70、110、150、190 keV)。
诊断标准与关键数值
- 图像质量采用Likert量表评分,1分为不可诊断,5分为优秀;伪影严重程度评分0分为无,5分为严重。
- iMAR神经线圈联合150 keV与190 keV VMI伪影减少最显著,中位评级1(标准为4)。
- 190 keV VMI图像质量中位评级3,70 keV VMI中位评级5。
- iMAR神经线圈联合190 keV VMI定量伪影表达平均20.06 HU,标准为167.98 HU,P<0.0001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to assess the impact of an iterative metal artifact reduction (iMAR) algorithm combined with virtual monoenergetic images (VMIs) for artifact reduction in photon-counting detector computed tomography (PCDCT) during interventions.
MATERIALS AND METHODS: Using an abdominal phantom, we conducted evaluations on the efficacy of iMAR and VMIs for mitigating image artifacts during interventions on a PCDCT. Four different puncture devices were employed under 2 scan modes (QuantumSn at 100 kV, Quantumplus at 140 kV) to simulate various clinical scenarios. Image reconstructions were initially performed without iMAR and subsequently with iMAR settings. The latter was tested with 7 different metal presets for each case. Furthermore, iMAR-reconstructed images were paired with VMIs at energy levels of 70 keV, 110 keV, 150 keV, and 190 keV. Qualitative assessments were conducted to evaluate image quality, artifact expression, and the emergence of new artifacts using a Likert scale. Image quality was rated on a scale of 1 (nondiagnostic) to 5 (excellent), whereas artifact severity was rated from 0 (none) to 5 (massive). Preferences for specific iMAR presets were documented. Quantitative analysis involved calculating Hounsfield unit (HU) differences between artifact-rich and artifact-free tissues.
RESULTS: Overall, 96 different scanning series were evaluated. The optimal combination for artifact reduction was found to be iMAR neurocoils with VMIs at 150 keV and 190 keV, showcasing the most substantial reduction in artifacts with a median rating of 1 (standard: 4). VMIs at higher keV levels, such as 190 keV, resulted in reduced image quality, as indicated by a median rating of 3 (compared with 70 keV with a median of 5). Newly emerged artifact expression related to reconstructions varied among intervention devices, with iMAR thoracic coils exhibiting the least extent of artifacts (median: 2) and iMAR neurocoils displaying the most pronounced artifacts (median: 4). Qualitative analysis favored the combination of iMAR neurocoils with VMIs at 70 keV, showcasing the best results. Conversely, quantitative analysis revealed that the combination of iMAR neurocoils with VMIs at 190 keV yielded the best results, with an average artifact expression of 20.06 HU (standard: 167.98 HU; P < 0.0001).
CONCLUSIONS: The study underscores a substantial reduction in artifacts associated with intervention devices during PCDCT scans through the synergistic application of VMI and iMAR techniques. Specifically, the combination of VMIs at 70 keV with iMAR neurocoils was preferred, leading to enhanced diagnostic assessability of surrounding tissues and target lesions. The study demonstrates the potential of iMAR and VMIs for PCDCT-guided interventions. These advancements could improve accuracy, safety, efficiency, and patient outcomes in clinical practice.
引用
- Layer YC, Faby S, Haase V, et al. Artifact Reduction in Interventional Devices Using Virtual Monoenergetic Images and Iterative Metal Artifact Reduction on Photon-Counting Detector CT. Invest Radiol. 2025. PMID: 39745893. doi:10.1097/RLI.0000000000001149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。